Cancer/Malignancies
CROI 2017: Stopping Smoking Cuts Risk of Some Cancers Quickly in People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 20 February 2017 00:00
- Written by Keith Alcorn
Smoking probably contributes far more to the risk of cardiovascular disease in people with HIV than antiretroviral drug choice, viral load, or any factor linked to the virus, but stopping smoking leads to a rapid reduction in the risk of some cancers, according to results from a cluster of studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections last week in Seattle.
CROI 2017: Treatment or Watchful Waiting for Cervical Abnormalities in Women with HIV?
- Details
- Category: HIV-Related Conditions
- Published on Wednesday, 15 February 2017 00:00
- Written by Carole Leach-Lemens
Close monitoring of earlier-stage cervical abnormalities (CIN-2) may be preferable to treatment for many women with HIV, a U.S. study suggests. The findings, presented at the Conference on Retroviruses and Opportunistic Infections this week in Seattle, show that CIN-2 regressed in over three-quarters of women taking antiretroviral therapy, without the need for CIN treatment. A higher CD4 count was associated with a lower likelihood that lesions would progress.
CROI 2016: Study Does Not Support Routine HPV Vaccination to Prevent Anal Cancer in People with HIV
- Details
- Category: Cancer/Malignancies
- Published on Tuesday, 01 March 2016 00:00
- Written by Keith Alcorn
The quadrivalent HPV vaccine Gardasil does not protect older adults with HIV against persistent anal infection with human papillomavirus or the development of high-grade anal lesions (HSIL), but the ACTG A5298 study showed some evidence that it may protect against persistent oral HPV infection, Timothy Wilkin of Weill Cornell Medical College reported at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last week in Boston.
IDWeek 2016: Only a Small Proportion of HIV+ Gay Men Receive Anal Cancer Screening
- Details
- Category: Cancer/Malignancies
- Published on Friday, 28 October 2016 00:00
- Written by Liz Highleyman
In the absence of national screening guidelines, only 11% of HIV-positive gay and bisexual men in the U.S. received anal Pap smears to detect anal cancer or precancerous cell changes during 2009-2012, with disparities between patient groups and variations across centers, according to a presentation at IDWeek, taking place this week in New Orleans.
CROI 2016: Early Antiretroviral Therapy Reduces the Risk of Infection-Related Cancers
- Details
- Category: Cancer/Malignancies
- Published on Friday, 26 February 2016 00:00
- Written by Keith Alcorn
People who started antiretroviral therapy at a CD4 cell count above 500 had a significantly lower risk of developing a cancer with an infectious cause when compared to people who started treatment at a CD4 count of 350 or below, an analysis of the START study presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston has shown.
More Articles...
- People with HIV Are at Higher Risk for Several Types of Cancer, Large Study Finds
- CROI 2015: Smoking Outweighs HIV-Related Risk Factors for Non-AIDS Cancers
- CROI 2015: Screening Finds High Prevalence of Early-Stage Lung Cancer in Smokers with HIV
- CROI 2015: Varenicline Helps People with HIV Stop Smoking, but Success Rate Remains Low